Feasibility and Safety Pilot Therapeutic Study of the Iron Chelator Deferiprone in Amyotrophic Lateral Sclerosis
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2017
Price : $35 *
At a glance
- Drugs Deferiprone (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms SAFEFAIRALS
- 08 Mar 2017 Status changed from active, no longer recruiting to completed.
- 17 Jun 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 25 Jun 2014 New trial record